Stem cell transplant (also known as bone marrow transplant) is an established treatment for many cancers and blood diseases once considered incurable. For some types of blood diseases, transplantation is the standard of care. For others, it is only considered if other treatments have not been successful. Ongoing advances in stem cell transplant are expanding its availability and improving outcomes for patients, young and old.
Meeting the Greatest Challenges
Here at the University of Chicago Medicine, the brightest minds in medicine are ready to meet the needs of all patients considering a stem cell transplant. We offer the latest promising approaches in blood and bone marrow stem cell transplant. Our team is known -- and recognized -- for our experience and expertise in:
- Alternative donor transplantation: Options for individuals lacking a related donor include haplo-cord transplants -- a combination of donated umbilical cord blood stem cells and half-matched (haploidentical) cells from a related donor.
- Integrated, disease-specific care: Our patients see physicians who are experts not only in transplantation but also in the patient’s specific cancer or blood disease, such as leukemia, lymphoma and multiple myeloma.
- Transplantation for the older adult: Recognizing the distinct needs of this population, we’ve assembled a multidisciplinary team of stem cell transplant and geriatric oncology experts to design a care program tailored specifically for patients over 60.
- Relapse prevention and treatment: Relapse remains the biggest challenge for cancer patients who have undergone stem cell transplantation. We are working tirelessly to lessen the risk of relapse and to improve outcomes for patients who experience this complication.
Dedicated Inpatient Unit
We provide outstanding and compassionate care in a patient-centered environment. The 28-bed Stem Cell Transplant Unit, located on the top floor of the Center for Care and Discovery, offers the newest technology as well as many thoughtful patient and family amenities.
As part of the internationally recognized University of Chicago Comprehensive Cancer Center (UCCCC), we participate in national clinical trials testing new and emerging therapies. A primary site for early-phase clinical trials, we offer our patients access to more new treatment protocols than any other hospital in the region.
Welcoming Patients from Near and Far
As a leading center for advanced care, the University of Chicago Medicine attracts patients from throughout the region, the country and around the world. We provide customized services for patients who travel from other countries. For more information, contact the Center for International Patients.
Birthplace of Bone Marrow Transplantation
In the late 1940s, University of Chicago researcher Dr. Leon Jacobson discovered that he could save a mouse, whose bone marrow and spleen had been destroyed with radiation, by transplanting healthy spleen tissue from another mouse. The donated tissue repopulated the marrow and restored production of the blood cells. This groundbreaking work influenced many scientists investigating bone marrow transplant for humans, including the winner of the 1990 Nobel Prize in Physiology or Medicine.
Pediatric Stem Cell Transplant
For information about stem cell transplant for children and teens, visit the Pediatric Stem Cell Transplant page on the University of Chicago Comer Children’s Hospital website.